OR2L3
gene geneOn this page
Summary
OR2L3 (olfactory receptor family 2 subfamily L member 3, HGNC:15009) is a protein-coding gene on chromosome 1q44, encoding Olfactory receptor 2L3 (Q8NG85). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 391192 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001004687
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15009 |
| Approved symbol | OR2L3 |
| Name | olfactory receptor family 2 subfamily L member 3 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000198128 |
| Ensembl biotype | protein_coding |
| Entrez | 391192 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000359959, ENST00000641161, ENST00000641649
RefSeq mRNA: 1 — MANE Select: NM_001004687
NM_001004687
CCDS: CCDS31104
Canonical transcript exons
ENST00000359959 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002392655 | 248060661 | 248063407 |
| ENSE00003813392 | 248046836 | 248046880 |
Expression profiles
Bgee: expression breadth broad, 19 present calls, max score 54.82.
Top tissues by expression
111 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 54.82 | silver quality |
| sural nerve | UBERON:0015488 | 46.53 | gold quality |
| ventricular zone | UBERON:0003053 | 44.20 | silver quality |
| primary visual cortex | UBERON:0002436 | 44.12 | silver quality |
| prefrontal cortex | UBERON:0000451 | 43.93 | silver quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 43.56 | gold quality |
| ganglionic eminence | UBERON:0004023 | 42.58 | gold quality |
| bone marrow cell | CL:0002092 | 40.51 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 40.38 | silver quality |
| calcaneal tendon | UBERON:0003701 | 40.29 | gold quality |
| frontal cortex | UBERON:0001870 | 40.21 | silver quality |
| monocyte | CL:0000576 | 39.97 | gold quality |
| cerebellar cortex | UBERON:0002129 | 39.50 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 39.33 | silver quality |
| cerebellum | UBERON:0002037 | 39.33 | silver quality |
| leukocyte | CL:0000738 | 38.86 | gold quality |
| substantia nigra | UBERON:0002038 | 38.70 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 38.60 | silver quality |
| hypothalamus | UBERON:0001898 | 38.56 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 38.41 | silver quality |
| apex of heart | UBERON:0002098 | 38.21 | silver quality |
| corpus callosum | UBERON:0002336 | 37.77 | gold quality |
| blood | UBERON:0000178 | 37.64 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 37.37 | gold quality |
| Ammon’s horn | UBERON:0001954 | 37.33 | silver quality |
| bone marrow | UBERON:0002371 | 37.31 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| muscle tissue | UBERON:0002385 | 36.96 | gold quality |
| endometrium | UBERON:0001295 | 36.52 | gold quality |
| amygdala | UBERON:0001876 | 36.25 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.12 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or2l5 | ENSMUSG00000045341 |
| rattus_norvegicus | Or2l5 | ENSRNOG00000081703 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310)
Protein
Protein identifiers
Olfactory receptor 2L3 — Q8NG85 (reviewed: Q8NG85)
All UniProt accessions (1): Q8NG85
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004687* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (23 total): topological domain 8, transmembrane region 7, sequence variant 4, glycosylation site 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NG85-F1 | 91.36 | 0.77 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 96–188
Glycosylation sites (2): 5, 88
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr1q44, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, SRPK2_TARGET_GENES, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
104 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2L3 | AK9 | Q5TCS8 | 419 |
| OR2L3 | PLBD1 | Q6P4A8 | 368 |
| OR2L3 | MMAB | Q96EY8 | 358 |
| OR2L3 | SLC22A10 | Q63ZE4 | 353 |
| OR2L3 | MAGEB16 | A2A368 | 353 |
| OR2L3 | SLC22A24 | Q8N4F4 | 353 |
| OR2L3 | MMS22L | Q6ZRQ5 | 351 |
| OR2L3 | DEGS2 | Q6QHC5 | 329 |
| OR2L3 | FXYD3 | Q14802 | 317 |
| OR2L3 | IQGAP3 | Q86VI3 | 311 |
| OR2L3 | TMEM244 | Q5VVB8 | 311 |
| OR2L3 | CDON | Q4KMG0 | 287 |
| OR2L3 | DYNC2H1 | Q8NCM8 | 279 |
| OR2L3 | NUP210 | Q8TEM1 | 271 |
| OR2L3 | RYR3 | Q15413 | 222 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A3KFT3, P0C628, P34982, P34985, P37068, P37071, Q15612, Q60879, Q8N146, Q8N162, Q8N349, Q8NG80, Q8NG81, Q8NG83, Q8NG85, Q8NG92, Q8NG95, Q8NGA1, Q8NGC7, Q8NGC8, Q8NGC9, Q8NGE0, Q8NGG4, Q8NGI8, Q8NGQ6, Q8NGS4, Q8NGY6, Q8NGY9, Q8NGZ0, Q8NGZ9, Q8NH16, Q8NH74, Q8NHA4, Q8NHB7, Q8NHC8, Q8VEX5, Q8VFR8, Q8VFV4, Q8VFX2, Q8VGI4
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
630 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:248046983:A:G | donor_gain | 0.9200 |
| 1:248051242:G:GG | donor_gain | 0.8900 |
| 1:248047783:GT:G | donor_gain | 0.8400 |
| 1:248048499:G:GT | donor_gain | 0.8400 |
| 1:248053058:GTAT:G | donor_gain | 0.8300 |
| 1:248053059:TATT:T | donor_gain | 0.8300 |
| 1:248053060:ATTA:A | donor_gain | 0.8300 |
| 1:248061564:G:GT | donor_gain | 0.8100 |
| 1:248047636:G:A | acceptor_gain | 0.8000 |
| 1:248053061:T:TG | donor_gain | 0.8000 |
| 1:248047635:C:CA | acceptor_gain | 0.7900 |
| 1:248061588:G:GG | donor_gain | 0.7900 |
| 1:248051186:AG:A | acceptor_gain | 0.7800 |
| 1:248051187:GG:G | acceptor_gain | 0.7800 |
| 1:248055340:C:A | donor_gain | 0.7600 |
| 1:248061586:GA:G | donor_gain | 0.7400 |
| 1:248048465:G:GT | donor_gain | 0.7300 |
| 1:248061324:T:G | acceptor_gain | 0.7300 |
| 1:248061451:C:G | acceptor_gain | 0.7200 |
| 1:248061449:C:G | acceptor_gain | 0.7000 |
| 1:248052963:TTAAG:T | acceptor_gain | 0.6900 |
| 1:248052964:TAAGT:T | acceptor_gain | 0.6900 |
| 1:248061323:AT:A | acceptor_gain | 0.6900 |
| 1:248061332:T:G | acceptor_gain | 0.6900 |
| 1:248061323:A:AG | acceptor_gain | 0.6800 |
| 1:248061005:TGCAG:T | donor_gain | 0.6700 |
| 1:248061314:T:TA | acceptor_gain | 0.6700 |
| 1:248061450:A:AG | acceptor_gain | 0.6700 |
| 1:248061570:A:AG | donor_gain | 0.6700 |
| 1:248052965:AAG:A | acceptor_gain | 0.6600 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000208081 (1:248060682 A>G), RS1000264473 (1:248054437 C>G), RS1000371688 (1:248048191 C>T), RS1000541941 (1:248061924 T>A), RS1000651166 (1:248055607 AT>A), RS1000707841 (1:248049700 C>T), RS1000722233 (1:248054128 T>C), RS1001122768 (1:248046661 T>C), RS1001175080 (1:248046390 A>G), RS1001597951 (1:248048622 C>T), RS1001866091 (1:248060170 C>A), RS1001887397 (1:248056287 AT>A,ATT), RS1001908278 (1:248055186 A>T), RS1001964548 (1:248049810 A>T), RS1002172149 (1:248044933 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| mancozeb | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Niclosamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.